Drug ID:   | NPD7361 |
Drug Name:   | HPH-116 |
Molecular Formula:   | C2H4N4O2 |
Canonical SMILES:   | OC(=N)/N=NC(=N)O |
Standard InCHI:   | InChI=1S/C2H4N4O2/c3-1(7)5-6-2(4)8/h(H2,3,7)(H2,4,8)/b6-5- |
Standard InCHIKey:   | XOZUGNYVDXMRKW-WAYWQWQTSA-N |
Max Developmental Stage:   | Phase 2 |
Max Developmental Stage Source:   | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
Similarity Level | Similarity Score | Natural Product ID |
---|---|---|
Intermediate Similarity | 0.7 | NPC142330 |
TTD   | DIB014336 |
DrugBank   | |
ChEMBL   | |
IUPHAR/BPS   | |
PharmaGKB   | |
KEGG Drug   | |
PubChem CID   | |
ChEBI   | |
CAS Number   |
Molecular Weight   | 116.03 |
ALogP   | -0.149 |
MLogP   | 1.02 |
XLogP   | 0.62 |
HDA   | 6 |
HBD   | 4 |
Rotatable Bonds   | 4 |
TPSA   | 112.88 |
RO5 Violation   | 0 |